Concepedia

Kelly Bell

KB

Statistics

Publications

18

Citations

817

H-Index

14

Active since

2010

Affiliations

AstraZeneca (United States)(Current)

Bristol-Myers Squibb (United States)

AstraZeneca (Singapore)

Centers for Disease Control and Prevention

Truven Health Analytics (United States)

Kelly Bell is an author at AstraZeneca (United States) specializing in diabetes mellitus, pharmacy, and diabetes management.

Publications per year

2010–2020

18

Publications

18

Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012

Bingcao Wu, Kelly Bell, Amy H. Stanford et al. · BMJ Open Diabetes Research & Care · 2016 · 215 citations · Full text

, , +15

Predictors of medication adherence in patients with type 2 diabetes mellitus

Suellen M. Curkendall, Nina Thomas, Kelly Bell et al. · Current Medical Research and Opinion · 2013 · 147 citations

, , +16

Mindfulness and rumination as predictors of persistence with a distress tolerance task

Greg Feldman, Emily Dunn, Carrie A. Stemke et al. · Personality and Individual Differences · 2013 · 92 citations

, , +9

The high-cost, type 2 diabetes mellitus patient: an analysis of managed care administrative data

Juliana Meyers, Shreekant Parasuraman, Kelly Bell et al. · Archives of Public Health · 2014 · 51 citations · Full text

, , +17

Economic burden of comorbid chronic kidney disease and diabetes

Robert B. McQueen, Sepehr Farahbakhshian, Kelly Bell et al. · Journal of Medical Economics · 2017 · 50 citations

, , +17

1–5 of 18